Understanding the pharmaceutical patent system in Spain and Europe: a perspective from the need to take its protection-access tradeoff seriously

In Iván Vargas-Chaves & Daniel Alzate-Mora (eds.), Derecho y Salud: debates contemporáneos. Sincelejo: Editorial CECAR. pp. 73-86 (2020)
  Copy   BIBTEX

Abstract

As a result of the doctoral research developed by the main author (Vargas-Chaves, 2017), it was identified the evolution and perspectives of the pharmaceutical patent in the international trade system, as well as it future legal research needs in this topic, both immediate and long-term. Furthermore, a number of problems of public health were highlighted in which the patent-term-extension mechanisms have produced a lack of access to medicines.

Other Versions

No versions found

Links

PhilArchive

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
Fair Drug Prices and the Patent System.David B. Resnik - 2004 - Health Care Analysis 12 (2):91-115.
Global Pharmaceutical Markets.Kevin Outterson & Donald W. Light - 1998 - In Helga Kuhse & Peter Singer (eds.), A Companion to Bioethics. Malden, Mass., USA: Wiley-Blackwell. pp. 417–429.
Are pharmaceutical patents protected by human rights?Joseph Millum - 2008 - Journal of Medical Ethics 34 (11):e25-e25.

Analytics

Added to PP
2020-05-27

Downloads
354 (#78,663)

6 months
51 (#99,633)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Citations of this work

No citations found.

Add more citations

References found in this work

Patentes farmacéuticas.Iván Vargas-Chaves - 2017 - Salamanca: Editorial Ratio Legis.

Add more references